EFPIA Vision

The voice of the pharmaceutical industry in Europe;
Fostering health: a shared commitment to high quality and sustainable healthcare

Read more
1
Innovative Medicines Initiative (IMI)

EFPIA contributes to IMI €223,7 million programme to tackle Antibiotic resistance

Read More
2
European Stakeholder Model (ESM)

The stakeholder-governed solution proposed by EFPIA and its partners in the pharmaceutical supply chain is indeed likely to constitute ...

Read More
3
Clinical Trials

Clinical Trials are tests in medical research needed for medicine development, and important to ensure the safety and quality of medicines

Read more
4
1
2
3
4

News

Nominations are now open for the Parliament Magazine's MEP Awards 2013  When and Where? Tuesday 25 June 2013 from 18.00, Concert Noble, Brussels  To...
The goal of this Conference is to look to the future: 2020 and three years beyond the end of the project, to how tools and knowledge provided through...
The Certificate in Healthcare Compliance Ethics & Regulation has been designed for Compliance Officers and Compliance Managers. It presents...

Press Release

Brussels: 23.04.13  On 18th April 2013 the Commission released its first report evaluating the effectiveness of the Memorandum of Understanding (MoU...
 Brussels, 19 April 2013 The European Federation of Pharmaceutical Industries & Associations (EFPIA), its specialised group the European...
Brussels 18.04.13: EFPIA, AESGP & EGA, as the collective voice of the European pharmaceutical industry, welcome the compromise announced...

Position Papers

This week the Indian Supreme Court denied the patent application of Novartis for its breakthrough medicines Glivec even though it was rewarded a...
EFPIA recognises that patients, researchers or the public are interested in knowing what new treatments are tested in clinical trials or what the...
Clinical trials are an essential part of medical research. No new medicine can be approved without its safety and efficacy first being proven in...

Latest entries

The 2013 eHealth week concluded yesterday, after 3 days of events that brought together industry partners, healthcare professionals, and decision-makers from across Europe to discuss the current possibilities and challenges facing eHealth. The event also offered the opportunity to celebrate eHealth...
Crisis is one word that has been used to describe the current state of research and development in the field of brain-related disorders.[1] Whether such terminology is justified or not is debatable, but there is no doubt that more needs to be done to address our knowledge gaps regarding brain-...